MRGPRX1
Basic information
Region (hg38): 11:18933499-18939414
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRGPRX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 16 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 11 | 2 |
Variants in MRGPRX1
This is a list of pathogenic ClinVar variants found in the MRGPRX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-18933824-C-G | not specified | Uncertain significance (Feb 09, 2023) | ||
11-18933836-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
11-18933855-C-G | not specified | Uncertain significance (Jan 23, 2024) | ||
11-18933863-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
11-18933890-A-G | not specified | Likely benign (May 17, 2023) | ||
11-18933939-T-C | Likely benign (Nov 01, 2022) | |||
11-18934003-G-T | not specified | Uncertain significance (Dec 13, 2023) | ||
11-18934055-C-T | not specified | Uncertain significance (Apr 08, 2023) | ||
11-18934095-C-T | Likely benign (Jul 01, 2022) | |||
11-18934099-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
11-18934118-G-A | Benign (Oct 19, 2017) | |||
11-18934139-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
11-18934179-A-G | Likely benign (Apr 01, 2023) | |||
11-18934187-T-C | Likely benign (Apr 01, 2023) | |||
11-18934206-C-A | Likely benign (Apr 01, 2023) | |||
11-18934207-C-A | Likely benign (Apr 01, 2023) | |||
11-18934222-C-A | not specified | Likely benign (Aug 01, 2022) | ||
11-18934241-C-A | not specified | Uncertain significance (Jun 23, 2021) | ||
11-18934292-A-G | not specified | Uncertain significance (Sep 01, 2021) | ||
11-18934304-A-G | not specified | Uncertain significance (Mar 20, 2024) | ||
11-18934381-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
11-18934406-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
11-18934438-A-C | not specified | Uncertain significance (Dec 14, 2021) | ||
11-18934484-C-T | not specified | Uncertain significance (Dec 19, 2023) | ||
11-18934554-G-C | not specified | Uncertain significance (May 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRGPRX1 | protein_coding | protein_coding | ENST00000302797 | 1 | 5695 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.918 | 219 | 184 | 1.19 | 0.0000116 | 2047 |
Missense in Polyphen | 32 | 30.657 | 1.0438 | 443 | ||
Synonymous | -3.80 | 128 | 83.7 | 1.53 | 0.00000561 | 695 |
Loss of Function |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | ||
East Asian | ||
Finnish | ||
European (Non-Finnish) | ||
Middle Eastern | ||
South Asian | ||
Other |
dbNSFP
Source:
- Function
- FUNCTION: Orphan receptor. Probably involved in the function of nociceptive neurons. May regulate nociceptor function and/or development, including the sensation or modulation of pain. Potently activated by enkephalins including BAM22 (bovine adrenal medulla peptide 22) and BAM (8-22)(PubMed:26582731). BAM22 is the most potent compound and evoked a large and dose-dependent release of intracellular calcium in stably transfected cells. G(alpha)q proteins are involved in the calcium-signaling pathway. Activated by the antimalarial drug, chloroquine. May mediate chloroquine- induced itch, in a histamine-independent manner. {ECO:0000269|PubMed:11850634, ECO:0000269|PubMed:20004959, ECO:0000269|PubMed:26582731}.;
Recessive Scores
- pRec
- 0.0624
Intolerance Scores
- loftool
- 0.291
- rvis_EVS
- 0.69
- rvis_percentile_EVS
- 85.18
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00421
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mrgprb2
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- acute-phase response;signal transduction;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;response to chloroquine
- Cellular component
- plasma membrane;cell surface;integral component of membrane
- Molecular function
- transmembrane signaling receptor activity;G protein-coupled receptor activity